Federal contract award

75N93024F00001

PRECLINICAL MODELS OF INFECTIOUS DISEASES

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIAID
NAICS541711
PSCAN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Parent award / vehicleHHSN272201700040I
Set-asideNot reported
Pricing typeCOST NO FEE
Obligations$1.2M
Current contract value$1.2M
Potential contract value / ceiling$1.7M
Start dateApr 15, 2024
Current end dateApr 14, 2026
Potential end dateApr 14, 2026
Latest award activityJan 23, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jan 23, 2026P00006$0ESTABLISHMENT OF A SMALL ANIMAL MODEL OF NIPAH VIRUS (NIV) INFECTION FOR ASSESSMENT OF MEDICAL COUNTERMEASURES EFFICACY.
Sep 30, 2025P00005$272.8KESTABLISHMENT OF A SMALL ANIMAL MODEL OF NIPAH VIRUS (NIV) INFECTION FOR ASSESSMENT OF MEDICAL COUNTERMEASURES EFFICACY.
Aug 28, 2025P00004$0ESTABLISHMENT OF A SMALL ANIMAL MODEL OF NIPAH VIRUS (NIV) INFECTION FOR ASSESSMENT OF MEDICAL COUNTERMEASURES EFFICACY.
Jun 3, 2025P00003$109.6KESTABLISHMENT OF A SMALL ANIMAL MODEL OF NIPAH VIRUS (NIV) INFECTION FOR ASSESSMENT OF MEDICAL COUNTERMEASURES EFFICACY.
Apr 30, 2025P00002$0EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025):: ESTABLISHMENT OF A SMALL ANIMAL MODEL OF NIPAH VIRUS (NIV) INFECTION FOR ASSESSMENT OF MEDICAL COUNTERMEASURES EFFICACY.
Mar 14, 2025P00001$0ESTABLISHMENT OF A SMALL ANIMAL MODEL OF NIPAH VIRUS (NIV) INFECTION FOR ASSESSMENT OF MEDICAL COUNTERMEASURES EFFICACY.
Apr 10, 20240$817.5KPRECLINICAL MODELS OF INFECTIOUS DISEASES

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.